Welcome to gatalin.co.uk

Gatalin^® XL is a prolonged-release capsule of galantamine indicated for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.¹

Available as:

Gatalin XL is bioequivalent to Reminyl^® (galantamine) XL (Shire Pharmaceuticals Limited, Hampshire, UK).²

Gatalin XL could offer significant cost savings to your practice and clinical commissioning group (CCG).

Galantamine 8mg, 16mg and 24mg prolonged-release capsules are in category C of the UK Drug Tariff.³

However, the NHS can make 50% savings on the cost of category C galantamine by prescribing Gatalin XL by brand name.^3*

Quite simply a wholesale switch of galantamine 8mg, 16mg and 24mg prolonged-release prescriptions to Gatalin XL could still save an average CCG £9,187 per year.^4**

Gatalin XL is one of Aspire Pharma’s cost saving prolonged-release products.

In addition Gatalin XL:

*50% saving on the cost of Category C galantamine prolonged-release capsules in the UK Drug Tariff. **Savings based on market data in reference 4. Savings calculated from 2019 spend for 218 CCGs switching their generic and originator brand 8mg, 16mg and 25mg galantamine prolonged-release capsule prescriptions to Gatalin XL. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review.

References: 1) Gatalin (galantamine) XL SmPCs. 2) Data on file. 1010067149 v 4.0 October 2019. 3) February 2020. UK Drug Tariff. 4) epact data Nov 2018 – Nov 2019 (UK)

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Gatalin XL, please see the abbreviated prescribing information.

Revision reference – Gatalin XL_23_23.03.2020